- Home
- CTSO vs EEA Comparison
CTSO vs EEA Comparison
Compare CTSO & EEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- EEA
- Stock Information
- Founded
- CTSO 1997
- EEA 1986
- Country
- CTSO United States
- EEA Germany
- Employees
- CTSO N/A
- EEA N/A
- Industry
- CTSO Medical/Dental Instruments
- EEA Trusts Except Educational Religious and Charitable
- Sector
- CTSO Health Care
- EEA Finance
- Exchange
- CTSO Nasdaq
- EEA Nasdaq
- Market Cap
- CTSO 52.6M
- EEA 67.9M
- IPO Year
- CTSO N/A
- EEA N/A
- Fundamental
- Price
- CTSO $1.03
- EEA $10.24
- Analyst Decision
- CTSO Buy
- EEA
- Analyst Count
- CTSO 2
- EEA 0
- Target Price
- CTSO $5.50
- EEA N/A
- AVG Volume (30 Days)
- CTSO 134.9K
- EEA 9.2K
- Earning Date
- CTSO 08-12-2025
- EEA 01-01-0001
- Dividend Yield
- CTSO N/A
- EEA 1.92%
- EPS Growth
- CTSO N/A
- EEA N/A
- EPS
- CTSO N/A
- EEA N/A
- Revenue
- CTSO $35,332,238.00
- EEA N/A
- Revenue This Year
- CTSO $18.34
- EEA N/A
- Revenue Next Year
- CTSO $19.82
- EEA N/A
- P/E Ratio
- CTSO N/A
- EEA N/A
- Revenue Growth
- CTSO 15.37
- EEA N/A
- 52 Week Low
- CTSO $0.71
- EEA $7.45
- 52 Week High
- CTSO $1.61
- EEA $9.26
- Technical
- Relative Strength Index (RSI)
- CTSO 49.00
- EEA 67.58
- Support Level
- CTSO $0.93
- EEA $9.85
- Resistance Level
- CTSO $1.39
- EEA $10.35
- Average True Range (ATR)
- CTSO 0.13
- EEA 0.13
- MACD
- CTSO -0.02
- EEA 0.01
- Stochastic Oscillator
- CTSO 34.92
- EEA 78.00
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.